Your browser doesn't support javascript.
loading
Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib.
Hu, Yuanqiong; Eynikel, Dimitri; Boulet, Pascale; Krikorian, Gaelle.
Affiliation
  • Hu Y; 1MSF Access Campaign, Médecins Sans Frontières, Rue de Lausanne 78, P. O Box 1016, CH-1211 Geneva 1, Switzerland.
  • Eynikel D; 2School of Law, School of Oriental and African Studies (SOAS), University of London, Russell Square, 10 Thornhaugh Street, Russell Square, London, WC1H OXG UK.
  • Boulet P; 3MSF Access Campaign, Médecins Sans Frontières, Rue de Lausanne 78, P. O Box 1016, CH-1211 Geneva 1, Switzerland.
  • Krikorian G; Medicines Law & Policy, 105 route de Lossiège, 74130 Contamine sur Arve, France.
J Pharm Policy Pract ; 13: 1, 2020.
Article in En | MEDLINE | ID: mdl-31956420
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pharm Policy Pract Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pharm Policy Pract Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom